Markel Group (NYSE: MKL) EVP sells shares and receives RSU award

Rhea-AI Filing Summary

Markel Group executive Wilson Simon reported both a stock sale and an equity award. On February 26, 2026, he completed an open-market sale of 100 shares of Markel Group common stock at a price of $2,079.4848 per share, leaving him with 2,396.7456 directly owned shares.

On February 24, 2026, he received a grant of 868.117 restricted stock units under the MKL 2024 Equity Incentive Compensation Plan at no purchase price. According to the award terms, 629.914 RSUs are scheduled to vest on December 31, 2028, and 238.203 RSUs are scheduled to vest on February 24, 2029, subject to applicable conditions.

Insights

Equity compensation and governance analyst

Routine mix of small share sale and long-dated RSU grant.

Markel Group executive Wilson Simon reported an open-market sale of 100 common shares at about $2,079.48 per share and an award of 868.117 restricted stock units under the 2024 equity plan. His directly held shares after the sale total 2,396.7456.

The RSUs vest in two tranches: 629.914 units on December 31, 2028 and 238.203 units on February 24, 2029, subject to stated conditions. This creates long-term alignment but does not imply near-term changes, as vesting extends several years.

Overall, these transactions appear consistent with standard executive compensation and portfolio management. The net effect is a modest reduction of currently held shares offset by future potential share delivery, with no additional context on performance conditions or broader compensation mix in this excerpt.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilson Simon

(Last) (First) (Middle)

C/O MARKEL GROUP INC.

4521 HIGHWOODS PARKWAY

(Street)

GLEN ALLEN VA 23060

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARKEL GROUP INC. [ MKL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CEO, Markel Insurance

3. Date of Earliest Transaction (Month/Day/Year)
02/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/24/2026		A		868.117(1)	A	$0	2,496.7456	D
Common Stock	02/26/2026		S		100	D	$2,079.4848	2,396.7456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units (RSUs) awarded pursuant to the MKL 2024 Equity Incentive Compensation Plan. Subject to certain conditions, 629.914 RSUs will vest on December 31, 2028, and 238.203 RSUs will vest on February 24, 2029.

Remarks:

	/s/ Karen O. Earls, Attorney-in-fact for Simon Wilson	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Markel Group (MKL) executive Wilson Simon report?

Wilson Simon reported two transactions: an open-market sale of 100 Markel Group common shares at about $2,079.48 per share and a grant of 868.117 restricted stock units under the MKL 2024 Equity Incentive Compensation Plan, both occurring in late February 2026.

How many Markel Group (MKL) shares did Wilson Simon sell and at what price?

He sold 100 shares of Markel Group common stock in an open-market transaction at a price of $2,079.4848 per share. This sale occurred on February 26, 2026, and was reported as a standard sale in the Form 4 insider filing for non-derivative common stock.

What equity award did Wilson Simon receive from Markel Group (MKL)?

He received an award of 868.117 restricted stock units under the MKL 2024 Equity Incentive Compensation Plan at no purchase price. These RSUs represent a form of deferred equity compensation that can convert into shares if vesting and other plan conditions are satisfied over time.

When will Wilson Simon’s Markel Group (MKL) restricted stock units vest?

According to the filing footnote, 629.914 of the awarded restricted stock units are scheduled to vest on December 31, 2028, and 238.203 units are scheduled to vest on February 24, 2029. All vesting remains subject to certain conditions specified in the company’s equity plan.

How many Markel Group (MKL) shares does Wilson Simon own after these transactions?

Following the reported open-market sale, Wilson Simon directly owns 2,396.7456 shares of Markel Group common stock. This figure reflects his holdings after selling 100 shares and does not yet include unvested restricted stock units, which may convert into shares only upon future vesting.

What is Wilson Simon’s role at Markel Group (MKL) mentioned in the Form 4?

The Form 4 identifies Wilson Simon as an officer of Markel Group, serving as Executive Vice President and CEO, Markel Insurance. His role description highlights that these reported transactions involve a senior executive, aligning them with typical equity-based compensation and personal portfolio activity.